secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001193125-25-272592
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health raises ~$717M via upsized equity and convertible debt offerings
-------------------------------------------------------------------------------

- Public offering of 3,833,332 shares at $90/share (incl. underwriter option), net proceeds ~$327.2M.
- Convertible notes: $402.5M principal, 0% coupon, due 2033, conversion price ~$121.50/share (35% premium).
- Net proceeds from notes ~$390M; combined ~$717M for general corporate purposes, including possible 2027 note repurchase.
- Both offerings upsized from initially announced amounts ($250M equity, $300M notes); closed Nov 7, 2025.
- Notes convertible under certain conditions after Feb 15, 2033; redeemable after Nov 20, 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312525272592/0001193125-25-272592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312525272592/d66171d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-272592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer